Purchase Order 75N92022P00296
Award Date 8/25/22
Potential Completion Date 9/24/22
Potential Value $95K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed-price purchase order valued at $24,438 to 10X Genomics, Inc., with an ultimate completion date of September 18, 2026. This contract, which carries no set-aside designation, represents a direct procurement of genomic analysis products or reagents from the Pleasanton, California-based biotechnology company. 10X Genomics specializes in advanced genomic analysis platforms, including single-cell and spatial...
- The National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $10,158 firm fixed price purchase order to 10X Genomics, Inc. for products and services to be delivered between July 2023 and July 2024. 10X Genomics, headquartered in Pleasanton, California, will provide genomic analysis tools and technologies to support NIH research initiatives. No subcontractors or set aside designations were indicated. This purchase augments NIH's ongoing...
- This federal contract award was made by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency under the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit biotechnology company headquartered in Pleasanton, California. The $24,861.50 firm-fixed-price purchase order contract has an ultimate completion date of August 20, 2026. The contract does not have a set-aside designation. 10X Genomics specializes in advanced genomic analysis...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed-price BPA (Blanket Purchase Agreement) call valued at $24,339 to 10X Genomics, Inc. on September 15, 2025, with completion scheduled for September 14, 2026. The contract procures two specialized genomic analysis products: Chromium Next GEM Chip H Single Cell Kit (16 reactions) and Chromium Next GEM Single Cell ATAC Kit V2 (16 reactions), both sourced from quotes referenced as SQ3272383V1. The award...
- 10X Genomics, Inc. was awarded a $11,000 firm fixed-price blanket purchase agreement (BPA) call contract by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) on April 13, 2022. The contract covers two 12-month Chromium Assurance Plans for instruments with serial numbers 60642 and 61748, with a period of performance from August 1, 2023 through July 31, 2024. This award was issued without a set-aside designation and was performed at the contractor's location in...
- The Department of Health and Human Services' National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $15,000 firm fixed price purchase order to 10X Genomics, Inc., located in Pleasanton, California. The contract is for unspecified products or services to be delivered between July 2023 and July 2024. 10X Genomics will perform as the prime contractor. No subcontractors, additional context, or set-aside designations were indicated in the award...
- This is a $19,248 firm fixed price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract, which has a completion date of January 24, 2026, does not have a set-aside designation. 10X Genomics is providing specialized scientific equipment,...
- This is a $12,000 firm fixed price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract has an ultimate completion date of July 4, 2026 and is not set aside. 10X Genomics specializes in single-cell and spatial genomic analysis solutions that support...
- 10X Genomics, Inc. is providing $24,999 worth of Chromium Next GEM Single Cell 3' Kit V3.1 products to the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases under a firm fixed price purchase order awarded on March 7, 2024. The place of performance is Pleasanton, California, with an expected completion date of March 6, 2025. The kit supports single cell RNA sequencing research efforts at the National Institute of Arthritis and Musculoskeletal...
- 10X Genomics, Inc. received a $24,970 firm fixed-price contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health, on April 13, 2022. This award, designated as a Blanket Purchase Agreement (BPA) call under contract number 23-002229, procures specialized genomic research consumables including Chromium Next GEM Single Cell Fixed RNA Sample Preparation Kits, Chromium Fixed RNA Kits for human transcriptome...